Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Interview: Dr. George Simon on Molecular Markers for Chemo Effectiveness in Lung Cancer
Author
Howard (Jack) West, MD

My friend George Simon, the Medical Director of the Thoracic Oncology Program at the Fox Chase Cancer Institute, is one of the leading experts in clinical research on the molecular correlates of the activity of chemotherapy in patients with lung cancer. We sat down together at the end of the recent World Conference on Lung Cancer to discuss some of this work and the general state of this growing field of research.

Here in audio version of the presentation, a pdf file of the figures, a transcript of our conversation, and the video version with the figures synchronized with the discussion.

[powerpress]

George Simon Audio Interview on Molecular Correlates with Chemo Activity in Lung Cancer

figures-gsimon-on-molecular-correlates-with-chemo-in-nsclc-in-lc

transcript-gsimon-on-molecular-correlates-with-chemo-in-nsclc-in-lc

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora